China has taken a major leap in medical technology by officially approving the world’s first commercially available brain–computer interface (BCI) designed to treat paralysis. This breakthrough marks a significant shift from experimental research to real-world application in neurotechnology.
The device, known as NEO, has been developed by Neuracle Medical Technology. It is engineered to convert brain signals into physical actions, offering new hope to individuals suffering from mobility loss due to spinal cord or neck injuries. The implant is currently intended for patients between the ages of 19 and 60.
After undergoing approximately 18 months of clinical trials, the device received approval from National Medical Products Administration. During testing, 32 patients were fitted with the implant, and no serious side effects were reported, reinforcing its safety profile.
The NEO implant is surgically placed within the skull and connects to the brain’s motor cortex using a network of electrodes. When a patient thinks about performing a movement, the system captures those signals and sends them to an external processor. This processor then translates the signals into real-world actions through assistive technologies such as robotic gloves.
In practical terms, this means users can perform basic everyday activities like holding objects or using utensils—tasks that were previously impossible due to paralysis.
While brain–computer interface research is advancing globally, most technologies are still in early testing phases. Even high-profile projects like Neuralink have not yet achieved full commercial approval for widespread use.
China’s progress is not accidental. The approval of NEO aligns with a broader national strategy aimed at dominating the BCI sector. Government plans outline a structured roadmap with 17 key initiatives designed to accelerate innovation, development, and commercialization within the next five years.
With this milestone, China has positioned itself at the forefront of a highly competitive and rapidly evolving field. The successful launch of a market-ready brain implant signals the beginning of a new era where thought-controlled technology could transform the lives of millions living with paralysis.

